BONT SRL
The score of BONT shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -96 % Total assets +66 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BONT's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 101,201 € | ||||
| Equity | 6,201 € | ||||
| Cash | 261,142 € | ||||
| EBITDA | 152,294 € | ||||
| Total assets | 307,284 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
BONT's financial analysis
- Solvency2.0%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BONT
BONT's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0773.840.660
- VAT number
- BE0773840660
- Peppol
- Registered · 0208:0773840660 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Sep 2021
- Registered office
- 2460 Kasterlee
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
BONT (SRL) has been based in Kasterlee since 2021, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 101,201 € and equity of 6,201 €; its revenue is not published. Its solvency stands at 2.0%, below the median of its sector (60.4%).
Companies similar to BONT
Companies in the same business, of comparable size and area, outside its group.
- Dr. Ghita Tagmouti Research and experimental development on natural sciences and engineering Antwerp · balance sheet 237,585 €
- Ergotrics Research and experimental development on natural sciences and engineering Turnhout · balance sheet 376,384 €
- Dokter Dries Tant Research and experimental development on natural sciences and engineering Bruges · balance sheet 555,867 €
- Cabinet de Médecine Générale André Hotermans Research and experimental development on natural sciences and engineering Stoumont · balance sheet 364,240 €
- Pharmacosmedics Research and experimental development on natural sciences and engineering Knokke-Heist · balance sheet 289,301 €
- Mentana DX Research and experimental development on natural sciences and engineering Evergem · balance sheet 229,998 €
- SciLife Consulting Research and experimental development on natural sciences and engineering Kortenberg · balance sheet 198,474 €
- DR.KRISTEL WAUTERS, cardiologie Medical specialists activities Kaprijke · balance sheet 283,883 €
Frequently asked questions about BONT
What is the revenue of BONT?
BONT files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BONT?
In Belgium, the VAT number is the company number prefixed with BE: BE0773840660 for BONT, if the company is VAT-registered. Its company number (CBE) is 0773.840.660.
Where is the registered office of BONT?
According to the CBE register, the registered office of BONT is in 2460 Kasterlee.
What is the equity of BONT?
At the close of the 2025 financial year, the equity of BONT amounts to 6,201 €, a solvency of 2.0% of total assets.
Who manages BONT?
The register lists 1 active mandates at BONT. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BONT
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →